I'm very pleased to address this issue, because it is of critical importance to Canadians.
I would want to stress that I'm not sure of the 18% figure. It's not one that I have here in front of me. But I guess I would want to reassure Canadians that in fact, as drugs go to market, we are very thorough in our reviews. We have very strong reviews of drugs as they go to market. We would want to reassure Canadians on the safety reviews that are done and on the efficacy reviews that are done as drugs come on the market.
But as was noted--